Hungarians conduct COVID drug experiments in space (article in Hungarian)

The COVID-19 epidemic posed new and pressing challenges for pharmaceutical researchers. Gilead Sciences’ Veklury was the first drug to treat COVID-19 infection that was provisionally approved in more than 50 countries. It is also the first product to receive a full, and therefore not temporary, and emergency license from the U.S. Food and Drug Administration (FDA) in October 2020…

….

Hungarian InnoStudio Zrt., Which is the leading international player in space chemistry as a new industry and CycloLab Kft., The primary European manufacturer of the excipient of remdesivir, is the first in the world to investigate the possible effects of microgravity during the remdesivir-SBECD interaction.

Read the full Hungarian article on 24.hu

Upcoming Events

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Social Media

Follow our daily updated Social Media pages for the latest news, event,curiosities and fun.

Latest News & Events

Latest Articles

Hungarians develop more effective COVID drugs in space

Hungarians develop more effective COVID drugs in space

Published May 7, 2021 on 24.hu In the last few months, in addition to vaccine developments against the coronavirus, little has been heard of regarding what efforts have been made to develop new medicines for the treatment of already covid infected patients. Regarding...

InnoStudio cited in the lead space journal by Roscosmos

InnoStudio cited in the lead space journal by Roscosmos

The recent and successful study of InnoStudio and CycloLab for COVID-19 drug research in space has been gaining attention and receiving positive feedback worldwide. The Roscosmos State Corporation for Space Activities found our idea and experiment valuable enough to...